Two more drugs, CIGB-258 and Itolizumab (Anti-CD6), manufactured by the Center for Genetic Engineering and Biotechnology (CIGB) have been added to Cuba’s arsenal of drugs in the fight against COVID-19. Dr. Francisco Duran, the National Director of Epidemiology... More »
Dr. Gerardo Guillén Nieto, the Director of Biomedical Research at the Center for Genetic Engineering and Biotechnology (CIGB), of the BioCubaFarma Group, said a clinical trial is taking place for a vaccine called CIGB 2020 to stimulate the immune system. The v... More »
More than 45 countries have requested Cuba’s Interferon Alpha 2B Recombinant, the only drug currently available to combat COVID19 (coronavirus). The drug is manufactured by the Center for Genetic Engineering and Biotechnology (CIGB) under the brand name Hebero... More »
Researchers and scientists from the BioCubaFarma group are currently developing new drugs to fight the spread of COVID-19. These new anti-viral drugs are based on prior research and clinical testing against other viruses. Clinical testing is ongoing and will b... More »
The Cuban skin cancer drug HeberFERON has demonstrated promising results in the treatment of skin cancer (basal cell carcinoma). HeberFERON, produced by Cuba’s Center for Genetic Engineering and Biotechnology (CIGB) has shown that the drug can significantly re... More »
